Contact Us
Drug Search Results
More Filters [+]

Carbasalate calcium

Alternative Names: carbasalate calcium
Latest Update: 2024-10-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PA Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Croatia | Iceland | Ireland | Latvia | Netherlands | Poland | Portugal | Romania | Switzerland

Approved Indications: None

Known Adverse Events: None

Company: Leiden University Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbasalate calcium

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hypertension|Atrial Fibrillation|Acute Coronary Syndrome|Stroke

Phase 3: Hypertension|Type 1 Diabetes|Arthritis, Rheumatoid

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
114180

P4

Unknown Status

Stroke

2031-09-02

BA-SCAD

P4

Unknown Status

Unknown

2026-02-28

WOEST 3 trial

P4

Active, not recruiting

Acute Coronary Syndrome|Atrial Fibrillation

2025-02-17

ASPIRETENSION

P4

Completed

Hypertension

2013-10-01

Recent News Events

Date

Type

Title

06/08/2022

PubMed

 Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.

02/21/2020

PubMed

 Successful percutaneous occlusion of a large left circumflex coronary artery fistula draining into the coronary sinus using a ventricular septal defect occluder: a case report.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions